AbbVie Inc. is set to enter the medical aesthetics space through its multi-billion dollar takeover of Allergan PLC.
In a shock announcement on 25 June, AbbVie said it will acquire Allergan for approximately $63bn in a cash and stock transaction. (Also see "AbbVie Pounces On Chance To...
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Medtech Insight for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?